Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8a39e72f61a9e226ed3e8a1223c38bb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 |
filingDate |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f712864cdc62b441e985d08c025df8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16fcacdb0a23d96b34dc21ec30fec9e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40aeddaa35c4ec10d153b0cacdaa773d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff8a96f268ad96a1b7780a6965d36ef1 |
publicationDate |
2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2385840-A1 |
titleOfInvention |
Materials and methods for the treatment of hypertension |
abstract |
The present invention is directed to materials and methods for the treatment of hypertension and ischemia comprising administering at least one therapeutic agent selected from the group consisting of vascular endothelial growth factor-C product and vascular endothelial growth factor-D product, and optionally, when treating hypertension, a standard of care anti-hypertensive agent. |
priorityDate |
2009-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |